Home
Conditions
Neurofibrosarcoma

Clinical trial condition

Neurofibrosarcoma

Explore clinical trials studying Neurofibrosarcoma. Study availability and eligibility vary by location and protocol.

72 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Neurofibrosarcoma trial results

Completed

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

NCT00041236

Conditions: Fibrosarcoma, Hemangiopericytoma, Malignant, Hemangiosarcoma, +25 more
Locations: Cliniques Universitaires Saint-Luc Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Aarhus University Hospital - Aarhus Sygehus - Norrebrogade Aarhus, Denmark

Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch Berlin, Germany

View Trial Details

Completed

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00041249

Conditions: Digestive System Diseases, Digestive System Neoplasms, Fibrosarcoma, +31 more
Locations: Universitair Ziekenhuis Antwerpen Edegem, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Centre Leon Berard Lyon, France

CHU de la Timone Marseille, France

View all 16 locations

View Trial Details

Completed

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

NCT00002764

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +62 more
Locations: Lund University Hospital Lund, Sweden

View Trial Details

Completed

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

NCT00003212

Conditions: Fibrosarcoma, Hemangiopericytoma, Malignant, Hemangiosarcoma, +25 more
Locations: Universitair Ziekenhuis Antwerpen Edegem, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Aarhus Kommunehospital Aarhus, Denmark

Rigshospitalet Copenhagen, Denmark

View all 23 locations

View Trial Details

Active, Not Recruiting

Natural History Study of Patients With Neurofibromatosis Type I

NCT00924196

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +38 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions: Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

View all 1007 locations

View Trial Details

Active, Not Recruiting

Tazemetostat in Malignant Peripheral Nerve Sheath Tumors

NCT04917042

Conditions: Behavior, Fibrosarcoma, Inhibition, Psychological, +16 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Active, Not Recruiting

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

NCT04483778

Conditions: Carcinoma, Clear Cell Sarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +66 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

NCT04420975

Conditions: Dermatofibrosarcoma, Fibrosarcoma, Histiocytoma, +48 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

NCT05677594

Conditions: Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease, +26 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Neurofibrosarcoma

Neurofibrosarcoma trial results

Related conditions